Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed250%
not_yet_recruiting250%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Effects of Sweetener Consumption on Risk Factors for Heart Disease in Prediabetic Subjects

NCT07377097
not_yet_recruitingnot_applicable

Short-Term Effects of Sucralose and Saccharin on Blood Sugar and Gut Microbiota in Type 2 Diabetes

NCT07124585
completednot_applicable

Microbiome and Non-caloric Sweeteners in Humans

NCT03708939
completednot_applicable

On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota

NCT02580110

Clinical Trials (4)

Showing 4 of 4 trials
NCT07377097Not Applicable

Effects of Sweetener Consumption on Risk Factors for Heart Disease in Prediabetic Subjects

Not Yet Recruiting
NCT07124585Not Applicable

Short-Term Effects of Sucralose and Saccharin on Blood Sugar and Gut Microbiota in Type 2 Diabetes

Not Yet Recruiting
NCT03708939Not Applicable

Microbiome and Non-caloric Sweeteners in Humans

Completed
NCT02580110Not Applicable

On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4